MOLNUPIRAVIR for Covid-19 treatment: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,476 adverse event reports in the FDA FAERS database where MOLNUPIRAVIR was used for Covid-19 treatment.
Most Reported Side Effects for MOLNUPIRAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product use issue | 706 | 14.8% | 21 | 41 |
| No adverse event | 614 | 12.8% | 0 | 2 |
| Covid-19 | 396 | 8.3% | 116 | 215 |
| Wrong technique in product usage process | 380 | 7.9% | 9 | 12 |
| Product use in unapproved indication | 296 | 6.2% | 3 | 14 |
| Diarrhoea | 259 | 5.4% | 14 | 45 |
| Accidental underdose | 207 | 4.3% | 0 | 4 |
| Product use complaint | 206 | 4.3% | 2 | 4 |
| Rash | 200 | 4.2% | 0 | 16 |
| Underdose | 183 | 3.8% | 4 | 4 |
| Nausea | 180 | 3.8% | 18 | 28 |
| Drug ineffective | 158 | 3.3% | 19 | 63 |
| Accidental overdose | 145 | 3.0% | 0 | 4 |
| Vomiting | 138 | 2.9% | 6 | 35 |
| Dizziness | 135 | 2.8% | 0 | 15 |
Other Indications for MOLNUPIRAVIR
Covid-19 (736)
Sars-cov-2 test positive (26)
Product used for unknown indication (15)
Covid-19 pneumonia (13)
Antiviral treatment (12)
Coronavirus infection (12)
Immunosuppressant drug therapy (9)
Pneumonia (8)
Covid-19 prophylaxis (7)
Post-acute covid-19 syndrome (6)
Other Drugs Used for Covid-19 treatment
NIRMATRELVIR\RITONAVIR (44,763)
CASIRIVIMAB\IMDEVIMAB (208)
REMDESIVIR (156)
CILGAVIMAB\TIXAGEVIMAB (146)
BAMLANIVIMAB\ETESEVIMAB (85)
HYDROXYCHLOROQUINE (71)
SOTROVIMAB (69)
BAMLANIVIMAB (66)
DEXAMETHASONE (60)
AZITHROMYCIN ANHYDROUS (47)